Home › Funds › Palisade Asset Management, LLC › ABT

Palisade Asset Management, LLC position in ABT

ABBOTT LABORATORIES · Health Care

Palisade Asset Management, LLC reported holding 201,522 shares of ABT (ABBOTT LABORATORIES) in its Q3 2026 13F filing — a position valued at US$19.9M, representing 1.89% of its reported portfolio and ranking #14 among its reported holdings. Palisade Asset Management, LLC has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)201.52K sh
Reported value held$19.92M
Portfolio Weight1.89%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Palisade Asset Management, LLC's ABT position evolved

Palisade Asset Management, LLC first disclosed a stake in ABT in Q3 2023 at 207,608 shares (US$20.1M). The position peaked in Q2 2025 at 214,363 shares, worth US$29.2M. Across 13 filings, Palisade Asset Management, LLC increased the stake 4 time(s), trimmed it 6 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 201,522 shares valued at US$19.9M — a reduction of -4,167 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 207.61K $20.11M New
Q4 2023 209.15K $23.02M Add
Q1 2024 248.02K $28.19M Add
Q2 2024 239.47K $24.88M Reduce
Q3 2024 235.50K $26.85M Reduce
Q4 2024 238.59K $26.99M Add
Q1 2025 216.20K $28.68M Reduce
Q2 2025 214.36K $29.16M Reduce
Q3 2025 214.76K $28.76M Hold
Q4 2025 203.98K $25.56M Reduce
Q1 2026 205.87K $21.14M Add
Q2 2026 205.69K $18.66M Hold
Q3 2026 201.52K $19.92M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABT and 13F data

ABT (ABBOTT LABORATORIES) is a Health Care company. 21 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), Charles Schwab Investment Management (US$5.41B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$5.41B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABT

All ABT fund holders →

FAQ

How long has Palisade Asset Management, LLC held ABT?

Palisade Asset Management, LLC has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Palisade Asset Management, LLC's current position in ABT?

As of Q3 2026, Palisade Asset Management, LLC holds 201.52K shares of ABT (ABBOTT LABORATORIES), valued at $19.92M, representing 1.89% of its reported portfolio and ranking #14.

Has Palisade Asset Management, LLC been buying or selling ABT?

In the latest 13F filing (Q3 2026), Palisade Asset Management, LLC reduced its position in ABT. The position peaked in Q2 2025 at 214.36K shares.

Which other funds hold ABT?

Other major institutional holders of ABT include Vanguard Group, Charles Schwab Investment Management, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, among 21 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.